Malaysia is a country in Southwest Asia with a relatively small size of population. In comparison to many societies with increasing proportions of senior citizens, its population is relatively young, and its economy is in a relatively high growth phase. Malaysia’s GDP is ranked 30th in the world in 2012....
Important developments in Malaysia’s drug legislations in 2012
Increase for chronic disease drug market, Decrease for infectious disease drug market
Conclusion
Figure 1 Market Values and Growth Rates of Top Ten Therapeutic Areas in Malaysia for 2012